JACRX | MGLCX | JACRX / MGLCX | |
Total Expense Ratio | 2.21 | 1.94 | 114% |
Annual Report Gross Expense Ratio | 2.21 | 1.95 | 113% |
Fund Existence | 14 years | 11 years | - |
Gain YTD | 9.261 | 3.043 | 304% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2500 | 1000 | 250% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 261M | 2.22B | 12% |
Annual Yield % from dividends | 1.65 | 1.29 | 128% |
Returns for 1 year | 8.86 | 1.39 | 636% |
Returns for 3 years | -0.89 | -6.36 | 14% |
Returns for 5 years | 6.13 | 9.38 | 65% |
Returns for 10 years | -12.42 | 9.12 | -136% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
HAGIX | 83.44 | 0.75 | +0.91% |
Carillon Eagle Mid Cap Growth I | |||
GLCTX | 32.10 | 0.19 | +0.60% |
Goldman Sachs Large Cap Gr Insghts Inv | |||
BUFEX | 58.96 | 0.22 | +0.37% |
Buffalo Blue Chip Growth | |||
LHCCX | 17.55 | 0.05 | +0.29% |
Lord Abbett Health Care C | |||
GCVTX | 24.41 | 0.07 | +0.29% |
Goldman Sachs Large Cp Val Insghts Inv |